- Home
- SFM vs DNTH Comparison
SFM vs DNTH Comparison
Compare SFM & DNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SFM | DNTH |
|---|---|---|
| Founded | 2002 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Food Chains | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.0B | 6.5B |
| IPO Year | 2013 | 2018 |
Fundamental Metrics
Financial Performance| Metric | SFM | DNTH |
|---|---|---|
| Price | $81.08 | $111.10 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 13 |
| Target Price | $98.89 | ★ $121.00 |
| AVG Volume (30 Days) | ★ 1.9M | 718.6K |
| Earning Date | 04-29-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 41.60 | N/A |
| EPS | ★ 3.08 | N/A |
| Revenue | ★ $8,806,159,000.00 | $2,036,000.00 |
| Revenue This Year | $8.95 | N/A |
| Revenue Next Year | $7.36 | $29.48 |
| P/E Ratio | $25.45 | ★ N/A |
| Revenue Growth | ★ 14.08 | N/A |
| 52 Week Low | $64.75 | $22.81 |
| 52 Week High | $147.16 | $117.88 |
Technical Indicators
Market Signals| Indicator | SFM | DNTH |
|---|---|---|
| Relative Strength Index (RSI) | 47.42 | 54.51 |
| Support Level | $76.35 | $79.27 |
| Resistance Level | $83.20 | $114.55 |
| Average True Range (ATR) | 2.92 | 5.11 |
| MACD | -0.66 | -0.55 |
| Stochastic Oscillator | 33.22 | 42.67 |
Price Performance
Historical ComparisonAbout SFM Sprouts Farmers Market Inc.
Sprouts Farmers Market Inc offers a specialty grocery experience featuring an open layout with fresh produce at the heart of the store. Sprouts inspire wellness naturally with a carefully curated assortment products paired with purpose-driven people. The company continues to bring products made with lifestyle-friendly ingredients such as organic, plant-based, and gluten-free. It approximately has 407 stores in nearly 23 states. The Company has one operating segment that is healthy grocery stores.
About DNTH Dianthus Therapeutics Inc.
Dianthus Therapeutics Inc. is a clinical-stage biotechnology company dedicated to developing potentially best-in-class therapies for patients with severe autoimmune diseases. The company operates as a single segment and has one reportable segment, focusing on creating next-generation treatments to revolutionize the management of severe autoimmune conditions. The team comprises experienced biotech and pharma executives. The pipeline includes the potential of Claseprubart, a next-generation complement therapeutic.